Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evolocumab in Acute Myocardial Infarction
NCT04082442Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Sep 2019
- Primary completion
- Oct 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of evolocumab in acute coronary syndrome (ACS), sponsored by Johns Hopkins University. Started Sep 2019; status: completed.
02
Drugs
evolocumab
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT04082442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04082442.